Optimal 57Co Flood Source Activity and
Acquisition Time for Lymphoscintigraphy
Localization Images
Martha V. Mar, Renee L. Dickinson, William D. Erwin, and Richard E. Wendt III
Division of Diagnostic Imaging, Department of Imaging Physics, University of Texas, M.D. Anderson Cancer Center, Houston, Texas

57Co

We evaluated different
flood source activities and acquisition times to obtain an optimal localization image for breast lymphoscintigraphy that would adequately outline the body and
allow detection of nodes seen on the emission scan while minimizing unnecessary radiation exposure to the patient. Methods:
An anthropomorphic thorax breast phantom representing an
average-size patient was used to simulate nodes on a breast
lymphoscintigraphy scan. The activities in the nodes at the
time of acquisition ranged from 37 to 185 kBq (1–5 mCi). Four experiments were performed, consisting of 10-min emission and
3-min localization images. Anterior, posterior, and right and left
lateral views of the thorax phantom were acquired, using each
of 5 different 57Co flood sources with activities ranging from 37
to 269 MBq (1.0–7.26 mCi). Ten 1-min localization images for
each source were acquired and compared for quality. Threeminute localization images for 2 phantom thicknesses of 10
and 20 cm were acquired to determine the contrast-to-noise ratio for each 57Co source. The total exposure was measured using
an ion chamber survey meter. Results: All sources allowed visualization of the lymphatic nodes in acquisitions as short as 3 min.
Images using the 126-MBq (3.41-mCi) source demonstrated an
adequate body outline along with visualization of all nodes
seen on the emission image. The 37-MBq (1.0-mCi) source did
not provide sufficient definition of the body outline, whereas
the hotter sources decreased node visualization by increasing
the background around the nodes at the same time that they increased the patient exposure. Node activity of 37 kBq (1 mCi) became undetectable on the anterior localization images yet was
still visible on the lateral image because of greater attenuation
of 57Co photons. The estimated dose rate from the 57Co sheet
sources was 0.641 mSv/MBq/h. Conclusion: Acquiring a 3-min
localization scan using a 126-MBq (3.41-mCi) source provided
the best combination of clear-body outline and visualization of
all nodes seen on the emission image. The estimated dose to
the patient from the 126-MBq (3.41-mCi) sheet source was
very low (8.7 mSv for unilateral and 13.1 mSv for bilateral). Node
detectability decreased in localization images acquired using
57Co sources of higher activity. This effect would be more pronounced in lymphoscintigrams of thin patients compared with
those of patients of average thickness.
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everal methods of outlining the body for lymphoscintigraphic localization imaging have been used clinically. One
of the first methods used was simply outlining the boundaries
of the patient’s body with a handheld point source during the
image acquisition (1). A similar but more complex method
used a small amount of 99mTc activity in a syringe to perform
a uniform sweep behind the patient (so-called activitybackground painting) to simulate the transmission of sheet
sources (2). Neither of these 2 methods is very practical because each is technically demanding and contributes to an
increase of radiation exposure, but both are inexpensive.
Another method of outlining the body contour is to acquire
the image with 2 separate energy windows: one to detect
primary photons from the 99mTc injection and the other to
detect scattered 99mTc photons (3). A more advanced method
is the use of a dual-head g-camera equipped with 153Gd–
attenuation correction line sources, which can be used to
generate an outline image (1). The line source is attached
to one detector, and simultaneous 99mTc-emission and
153Gd-planar localization images are acquired with the other
detector. This technique can also be applied in the anterior or
lateral projections or at other projection angles if needed.
Currently, the most detailed localization images are SPECT/
CT fusion images, which are superior to any patient outlining or backlighting technique because of the detailed,
3-dimensional anatomic localization capability (4). Although
the methods discussed here have found limited acceptance
for lymphoscintigraphy localization, the use of 57Co flood
source backlighting for lymphoscintigraphy imaging continues to be the most popular (5,6).
The popularity of the 57Co backlighting method is most
likely because of the ready availability of the 57Co flood
source; most clinical nuclear medicine departments use
57Co sheet sources for daily quality-control testing and for
collimator or extrinsic uniformity calibration for planar and
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SPECT imaging. In facilities where more than 1 source is
available, the question may arise as to which source activity
would provide optimal localization imaging with the least
amount of radiation exposure to the patient. The current study
evaluated different source activities and image-acquisition
times to improve lymphoscintigraphy localization imaging.
The best imaging parameters were determined by ensuring
that all lymph nodes visualized in the emission scan would
also appear on the localization image while at the same
time guaranteeing an adequate body outline to determine
anatomic location. The dependence of the choice of best
parameter on patient thickness was also evaluated.
Competing processes are at work when backlighting a
lymphoscintigram with a 57Co sheet source. Because the
nodes themselves have a fixed activity, the more photons
that penetrate the patient per unit time (a factor that
depends directly on the 57Co sheet source activity), the
more likely the photons will mask the nodes in the image
by reducing the node-to-background contrast. At the same

time, a clear outline of the body requires a sufficient
number of counts from the 57Co source (where the number
of counts necessary to adequately outline the body is
reached by increasing the source activity or by increasing
the acquisition time). The goal of this study was to find
the sheet source activity and acquisition time for the
57Co-backlighting image acquisition that offers the best
compromise between body outline delineation and node
detectability of a lymph node that is visualized in the planar
emission scan.

MATERIALS AND METHODS
A modified anthropomorphic thorax breast phantom (Radiology Support Devices) representing an average-size (23-cm anteroposterior thickness) patient in combination with fillable spheres
representing the injection site (4.0 mL) and lymph nodes (0.063
mL) was used to mimic 2 nodes on a breast lymphoscintigraphy
scan (Figs. 1A and 1B).

FIGURE 1. Modified anthropomorphic
thorax breast phantom used to simulate
breast lymphoscintigraphy injection-site
uptake (A) and lymphatic drainage to 2
nodes (B).
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The first of 4 experiments consisted of acquisitions of 10-min
baseline emission images of the thorax phantom for all 4 common
lymphoscintigraphic views: anterior, posterior, left lateral, and
right lateral. Then, localization images for each of 5 different 57Co
flood sources with activities of 37, 126, 184, 220, and 269 MBq
(1.0, 3.41, 4.96, 5.94, and 7.26 mCi) were acquired as a dynamic
series of ten 1-min images. The individual 1-min dynamic images
were summed to obtain 1-, 2-, 3-, 4-, 5-, 6-, 7-, 8-, 9-, and 10-min
images. This collection of images with a range of count statistics
was used to determine the shortest acquisition time that would
yield adequate image quality.
After determining the shortest acquisition time for the transmission image, we conducted the second experiment, which
consisted of 10-min emission and shortest acquisition-time localization images of anterior, posterior, and right and left lateral
views of the thorax phantom, acquired with each of the 5 different
57Co flood sources. These images were used to verify the detectability of nodes. The initial emission and dynamic localization
images were acquired with an activity of 93 MBq (2.5 mCi) for
the injection site, 185 kBq (5 mCi) for the spheric node, and
74 kBq (2 mCi) for the spheric node of 99mTc-pertechnetate. A
second set of images used to verify node detectability using the
optimal source activity was acquired with a lower activity of 56
MBq (1.5 mCi) for the injection site, 148 kBq (4 mCi) for the
spheric node, and 37 kBq (1 mCi) for the spheric node of 99mTcpertechnetate. The injection site and lymph node activities for the
phantom were determined by a 200-patient retrospective chart
review and are representative of the average activity range of
99mTc drainage to lymph nodes for breast lymphoscintigraphy
studies (7). All images were acquired using low-energy, ultrahigh-resolution collimators (256 · 256 matrix), with our standard
clinical energy window used for imaging 99mTc: 15% width,
centered on 140 keV.
Ideally the patient would attenuate all of the photons from the
57Co sheet source. However, body sizes and hence transmission
factors of patients vary, which necessitated an investigation of how
the quality of the localization images would change given different anteroposterior and lateral thicknesses. Two nodes of approximately 37 and 148 kBq (1 and 4 mCi) were embedded into
simulated adipose tissue (Superflab; Mick Radio-Nuclear Instruments, Inc.); different thicknesses of acrylic blocks (10 and 20 cm)
were placed on the imaging couch with the Superflab and nodes
on top. An additional acrylic block (5 cm thick) was placed over
the nodes as a scatter medium. Three-minute localization images
for the 2 block thicknesses of 10 and 20 cm were acquired for
each 57Co source, with the anterior collimator-to-node distance
held constant. An identical region of interest (ROI) was drawn
around each of the nodes and in the background. A contrast-tonoise ratio was calculated by taking the node ROI total counts,
subtracting the total background counts in the identically sized
background ROI, and dividing the results by the square root of the
total background counts. This calculation was performed to ensure
that the suggested source activity for lymphoscintigraphy was
adequate for a wide range of patient sizes; the contrast-to-noise
calculation was used to quantitatively assess whether a node
would be visualized in an image with a known background
activity.
Radiation-absorbed doses to the patient from each source were
estimated on the basis of exposure measurements made with an
ion chamber (Inovision 451B; Fluke) in rate mode. The meter was
placed on top of the bed, with acrylic blocks surrounding the
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survey meter to simulate patient scatter. The 57Co sources were
placed one at a time on the face of the posterior detector, an
arrangement similar to the one when scanning a patient, and the
measured exposure rate for each sheet source was recorded (the
mSv/h meter readings were assumed equivalent to effective dose
rate, which is a conservative assumption). Lymphoscintigraphy
studies require exposing the patient to 57Co sheet sources for each
of the views used to localize sentinel lymph nodes; the radiation
absorbed for each individual view was calculated by multiplying
each dose measurement by the time the patient would be exposed
to the sheet source (3 min):
Dose per view ½mSv 5 ðdose rateÞ · ðtime per viewÞ
Dose per view ½mSv 5 ðmSv=hÞ · ðhÞ:
The total estimated dose to the patient for a lymphatic study
depends on whether the study is a bilateral or unilateral breast
study; bilateral studies require 3 views for the transmission imaging (anterior, right lateral, and left lateral transmission images),
whereas unilateral studies require only 2 views:
Total dose ½mSv 5 ðdose per viewÞ · ðnumber of viewsÞ:

RESULTS

The first experiment established the shortest acceptable
localization acquisition time to be 3 min. All sources ranging from 37 to 269 MBq (1.0–7.26 mCi) allowed visualization of the lymphatic nodes with an acquisition time as
short as 3 min (Figs. 2A–2D). The 1- and 2-min anterior
localization images did not allow visualization of the 74kBq (2-mCi) spheric node; however, the 74-kBq (2-mCi)
spheric node was visible in the lateral image (Figs. 2C and
2D). The node was not visualized in the anterior image because of the higher background counts arising from transmission of the 57Co backlighting photons through a smaller
thickness of the simulated patient.
The second experiment used the shortest acquisition time
from the first experiment to evaluate the source activity that
would provide an adequate body outline while allowing
visualization of all nodes seen on the emission scan. The
126-MBq (3.41-mCi) 57Co sheet source provided the best
compromise between clarity of the body outline and visualization of the weakest nodes (Figs. 2C and 2D). The
37-MBq (1.0-mCi) source did not provide a sufficiently distinct body outline, whereas the hotter sources increased the
transmitted background counts around the nodes, thereby
decreasing the contrast to the point of masking the node
within the background.
After we determined an adequate source activity for
body outline and node detectability, we acquired a 10-min
emission image and 3-min localization image at that source
activity with a lower activity of 56 MBq (1.5 mCi) in the
injection-site sphere, a 148-kBq (4 mCi) spheric node, and a
37-kBq (1-mCi) spheric node. Node activities of 37 kBq
(1 mCi) were undetectable on the anterior transmission
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FIGURE 2. Different 57Co sources (activities of 37, 126, 184, 220, and 269 MBq) allowed visualization of both nodes with
acquisition time of 3 min (A–D). Anterior localization images (1 and 2 min) did not show both nodes; however, both nodes were
visible on lateral images (C and D).

images yet were still visible on the lateral image because of
the greater attenuation of the transmitted 57Co photons in
that orientation (Fig. 3). The lateral localization image (34cm lateral phantom thickness) shows lower-activity nodes
because of increased attenuation of 57Co photons by more
tissue; the reduction in counted 57Co photons reduces the
background, which increases the contrast and increases
node detectability. The anterior view (23-cm anteroposterior phantom thickness) has less attenuation of photons than
the lateral view because the photons have less tissue to
traverse (2). The contrast in the anterior view is lower than
that in the lateral view because of an increase of transmitted
57Co photons detected within the outline of the patient,
which increases the background and thus decreases the
visualization of low-activity nodes (as was the case with the
second spheric node with an activity of 37 kBq).

The third test was performed to ensure that the selected
source activity would work both for average-size and thin
patients. Table 1 and Figure 4 demonstrate the effect of attenuation of the 57Co photons between 10- and 20-cm body
thicknesses, indicating that node detectability on localization images will decrease with thinner patients, depending
on the 57Co activity.
The last experiment compared the estimated effective
dose to the patient for the 5 different source activities
available. Linear regressions of estimated effective dose
versus 57Co sheet source activity for unilateral and bilateral
protocols yielded the functions y 5 0.1x 2 0.4 and y 5
0.1x 2 0.5, respectively. The calculated estimate of dose
rate was 0.641 mSv/MBq/h. The best source activity for
imaging 126 MBq (3.41 mCi) exposes patients to 8.7 mSv
for total unilateral studies and 13.1 mSv for total bilateral
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FIGURE 3. Node activities of 37 kBq
were undetectable on anterior transmission images; however, they were visible
on lateral transmission images using 126MBq (3.41-mCi) 57Co flood source.

studies (Table 2). Any additional single views would add
approximately 4.4 mSv each to the patient’s absorbed dose.
DISCUSSION

Technologists should be informed about the competing
processes occurring during the acquisition of lymphoscintigram transmission imaging to provide the best images. In
addition, technologists should be aware that when the source
activity is less than the minimum activity for adequate
delineation of the body outline, it is possible to improve the
image quality by increasing the acquisition time proportionally. Consequently, the study time will be lengthened while

the radiation exposure to the patient would be at best
equivalent, and possibly greater. Hotter sources provide
acceptable body outline with decreased scan time for the
localization image, but the nodes may not be visualized
because of a decreased node-to-background ratio. As the
node activity decreases below 37 kBq (1 mCi), the node is
masked in the localization image acquired with a higher
activity source because a higher number of 57Co photons
penetrate through the patient and are counted, creating a
higher background, and the same number of counts are
detected from the node. Hotter sources increase the patient
and technologists’ radiation exposure during acquisition and
setup time.

TABLE 1
CNR Calculations for 2 Block Thicknesses: 10 cm (Thin Patient) and 20 cm (Average Patient)
57Co source
activity (MBq)

10-cm-thick acrylic
37
126
184
220
269
20-cm-thick acrylic
37
126
184
220
269

Node 1
(total counts)

Node 2
(total counts)

Background
(mean counts)

No. of pixels in
background ROI

CNR node 1

CNR node 2

169
158
176
185
213

505
514
537
582
550

0.52
0.89
1.15
2.00
2.48

27
27
27
27
27

41.4
27.3
26.0
17.8
17.8

131.0
100.0
90.8
71.9
59.0

139
153
156
178
133

469
442
471
480
483

0.35
0.42
0.62
0.81
0.85

25
25
25
25
25

44.0
44.0
35.7
35.1
24.2

155.6
133.2
115.7
102.2
100.2

CNR 5 contrast-to-noise ratio.
Node detectability for transmission imaging decreases with thinner patients.

86

JOURNAL

OF

NUCLEAR MEDICINE TECHNOLOGY • Vol. 36 • No. 2 • June 2008

use of planar lymphoscintigraphy imaging for initial preoperative lymphatic mapping (4,8,9).
CONCLUSION

FIGURE 4. Plot of contrast-to-noise ratio versus source activity and block thickness for 2 node strengths.

The source activity used for transmission imaging is also
affected by the various patient thicknesses. The results from
the study using the 10- and 20-cm blocks showed that the
contrast-to-noise ratio is higher for 20-cm than for 10-cm
thicknesses because the body causes greater source photon
attenuation at 20-cm thicknesses during localization imaging. Using high-activity sources will more significantly
mask the nodes during transmission imaging in thin patients than in average patients. This is because of a greater
number of 57Co photons penetrating through less body,
creating more background counts that mask the nodes. If
one has a choice of 2 sources, using the lower activity for
thin patients is recommended because thin patients will be
the most affected because of the higher number of 57Co
photons penetrating through the patient and creating a
higher background that will mask the node.
The objective of transmission scans is to see lymph
nodes on the localization image that appear on the emission
scan with sufficient body outline to determine the anatomic
location, whereas the purpose of the emission scan is node
detectability. Nonvisualization of lymph nodes during planar emission imaging occurs when the lymph nodes are
close to the injection site or if they are located too deep
within the patient. Several authors describe the use of
SPECT/CT as an additional tool for inconclusive and
unusual lymphoscintigram cases but do not eliminate the

TABLE 2
Effective Dose Estimates for 57Co Source Activities Given
Standard 3-Minute Transmission Scans
57Co
source
activity
(MBq)

37
126
184
220
269

Measured
exposure
rate
(mSv/h)

Exposure
for single
view
(mSv)

Total for
unilateral
study
(mSv)

Total for
bilateral
study
(mSv)

20
87
113
145
178

1.00
4.35
5.65
7.25
8.90

2.0
8.7
11.3
14.5
17.8

3.0
13.1
17.0
21.8
26.7

Acquiring a 3-min localization image using a 126-MBq
(3.41-mCi) source produced an adequate body outline while
allowing visualization of all nodes seen on the emission
image. These results suggest that the best source activity
should be greater than 37 MBq (1.0 mCi) but not greater than
185 MBq (5.0 mCi). Node detectability decreased on localization images when using hotter 57Co sources. This effect
would be more pronounced in thin (10 cm) than in average
patients. The estimated dose to the patient for 126 MBq
(3.41 mCi) was acceptable (8.7 mSv for unilateral and
13.1 mSv for bilateral examinations) and can be estimated
for any activity sheet source from the results in Table 2 (i.e.,
an average expected dose rate is 0.641 mSv/MBq/h).
Typically, flood sources used for nuclear medicine
quality-assurance testing and calibration range from 185
to 555 MBq (5–15 mCi). Institutions that routinely dispose
of 57Co sheet sources that have decayed below 185 MBq
(5 mCi) should consider keeping a decayed source for
1 extra replacement cycle (typically 9–12 mo), so that they
would have a source of less than 185 MBq (5 mCi) to use
for backlighting lymphoscintigrams. This is important for
clinics that currently have only a single sheet source that is
used both for g-camera quality control and for backlighting
for localization in lymphoscintigraphy. The results of this
study suggest that both functions cannot be performed
optimally with the same sheet source. Facilities that have
more than 1 sheet source available should avoid using
sources stronger than 185 MBq (5 mCi) for 57Co backlighting.
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